The deal, which is worth $95 billion including Celgene's debt, is the largest pharmaceutical deal ever and brings together two of the world's largest cancer drug businesses. Celgene's top executives, including its chief executive officer and chief financial officer, are entitled to severance

https://finance.yahoo.com/news/celgene-bristol-myers-set-2-143935072.html